Search
for

    Research

    5 / 1000+ results
      Redefining Hormone Resistance in Prostate Cancer

      research Redefining hormone resistance in prostate cancer

      38 citations , December 2009 in “Therapeutic Advances in Medical Oncology”
      This discussion proposes a model to incorporate patients with hormone-resistant prostate cancer into the existing framework by redefining hormone resistance and exploring new therapeutic approaches.
      Prostate Cancer Update: 2007

      research Prostate cancer update: 2007

      August 2008 in “Current Opinion in Internal Medicine”
      This review discusses significant developments in prostate cancer risk assessment, diagnosis, and treatment, but reports no new clinical results; the authors emphasize the evolving importance of prognostic factors and treatment implications.

      research Doxetaxel: new indication. Prostate cancer: a few more weeks.

      February 2006 in “PubMed”
      In this study, docetaxel combined with prednisone significantly extended survival by about 2.5 months in men with hormone-resistant metastatic prostate cancer compared to mitoxantrone plus prednisone, despite the potential for severe adverse effects.

    Community Join

    5 / 1000+ results